AN2 Therapeutics Inc Financial Flexibility Index
AN2 Therapeutics Inc financial flexibility index. AN2 Therapeutics Inc (ANTX) has a Financial Flexibility Index of -1.22x as of June 2026. Free cash flow of $-7.00 Million (operating CF $-7.00 Million minus capex $0.00) represents -1% of total liabilities ($5.75 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AN2 Therapeutics Inc (2019–2025)
Financial flexibility index of AN2 Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for AN2 Therapeutics Inc across 7 annual periods. Explore ANTX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
AN2 Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
AN2 Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for AN2 Therapeutics Inc. For the full cash flow conversion analysis, see AN2 Therapeutics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-29.83 Million | $-29.83 Million | $8.89 Million | ▲ +30.2% |
| 2024 | -4.81x | $-49.26 Million | $-49.26 Million | $10.24 Million | ▼ -26.8% |
| 2023 | -3.79x | $-53.29 Million | $-53.29 Million | $14.04 Million | ▲ +18.5% |
| 2022 | -4.66x | $-33.46 Million | $-33.46 Million | $7.19 Million | ▲ +22.5% |
| 2021 | -6.01x | $-20.48 Million | $-20.48 Million | $3.41 Million | ▼ -66.2% |
| 2020 | -3.62x | $-5.36 Million | $-5.36 Million | $1.48 Million | ▼ -29.1% |
| 2019 | -2.80x | $-2.49 Million | $-2.49 Million | $887.00K | — |